FDA Fiddles With Remote Drug Inspections While Pharma Burns

FDA Fiddles With Remote Drug Inspections While Pharma Burns

Source: 
FDA Law Blog
snippet: 

For over nine months FDA has dithered on whether and, if so how, to conduct remote inspections of drug facilities during the pandemic.  On the other hand, many foreign regulatory bodies appear to have implemented just such a system of remote inspections. Has FDA just decided to wait out the pandemic?  Hyman, Phelps & McNamara, P.C.’s Mark I. Schwartz discussed this issue and more in an op-ed published earlier this week with Bloomberg News.